首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿霉素、顺铂为主的联合化疗治疗卵巢恶性肿瘤
引用本文:刘履光,张涛.阿霉素、顺铂为主的联合化疗治疗卵巢恶性肿瘤[J].华中科技大学学报(医学版),1994(5).
作者姓名:刘履光  张涛
作者单位:同济医科大学附属协和医院肿瘤科!武汉430022
摘    要:1988年11月至1993年2月共收治卵巢恶性肿瘤19例,其中复发性卵巢癌9例,卵巢转移癌10例。采用以阿霉素、顺铂为主的联合化疗方案,15例有腹水者经上述治疗后,显效4例,有效9例,客观有效率为86.7%;9例复发性卵巢癌化疗后完全缓解6例、部分缓解1例,有效率为77.8%。其中3例再次手术后辅以化疗,生存时间延长,1例已存活4年余。全组未发生严重地毒副作用。治疗结果显示,以阿霉素、顺铂为主的联合化疗方案对复发性和卵巢转移癌不失为一有效的治疗方法。

关 键 词:阿霉素  顺铂  卵巢肿瘤

Cisplatin and Adriamycin Combination Chemotherapy for Advanced Ovariocarcinoma
Liu Luguang,Zhang TaoDeparment of Oncology,Xiehe Hospital,Tongji Medical University,Wuhan.Cisplatin and Adriamycin Combination Chemotherapy for Advanced Ovariocarcinoma[J].Journal of Huazhong University of Science and Technology(Health Sciences),1994(5).
Authors:Liu Luguang  Zhang TaoDeparment of Oncology  Xiehe Hospital  Tongji Medical University  Wuhan
Institution:Liu Luguang,Zhang TaoDeparment of Oncology,Xiehe Hospital,Tongji Medical University,Wuhan 430022
Abstract:19 patients with advanced ovariocarcinoma were treated during Novermber 1988 to February 1993.In these cases,9 had recurrent ovariocarcinoma and 10 had metastatic ovariocarcinma.They were given the regimen of combination chemotherapy of cisplatin (DDP) and Adriamycin (ADM).Among the 15 patients with ascites,the remarkable efffects in controlling malignant ascites were gained in 4 cases and ascites reduction was noted in 9 cases.The overall responsece rate was 86.7%.In 9 cases with recurrence the overall response rate was 77.8%,with 6 patients having complete remmision and 1 patient achiving partial remmision.In second group 3 patients received second operation. In all of these patients,no remarkable toxicity reaction was observed and the survival time was prolonged.One patient has survived for 4 years.The results indicate that the combination chemotherapy of DDP and ADM is a effective regimen for advanced recurrent and inetastatic ovariocarcinoma.
Keywords:adriamycin  cisplatin  ovariocarcinoma
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号